Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIMA-C: DAPT Duration After 2nd Gen DES
NCT03056118Phase 4Completed
- Sponsor
- Gangnam Severance Hospital
- Start
- May 2011
- Primary completion
- Jun 2015
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of clopidogrel in ischemic heart disease (IHD), sponsored by Gangnam Severance Hospital. Started May 2011; status: completed.
02
Drugs
clopidogrel
03
Conditions
ischemic heart disease (IHD)
Beyond the preview
Go deeper on NCT03056118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03056118.